James V. Caruso
2020
In 2020, James V. Caruso earned a total compensation of $1M as President and Chief Executive Officer at Cellectar Biosciences, a 9% increase compared to previous year.
Compensation breakdown
Bonus | $332,500 |
---|---|
Option Awards | $208,740 |
Salary | $475,000 |
Total | $1,016,240 |
Caruso received $475K in salary, accounting for 47% of the total pay in 2020.
Caruso also received $332.5K in bonus and $208.7K in option awards.
Rankings
In 2020, James V. Caruso's compensation ranked 8,566th out of 13,090 executives tracked by ExecPay. In other words, Caruso earned more than 34.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,566 out of 13,090 | 35th |
Division Manufacturing | 3,646 out of 5,624 | 35th |
Major group Chemicals And Allied Products | 1,474 out of 2,257 | 35th |
Industry group Drugs | 1,283 out of 1,957 | 34th |
Industry Pharmaceutical Preparations | 948 out of 1,462 | 35th |
Source: SEC filing on May 13, 2021.
Caruso's colleagues
We found four more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2020.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019